Institutional Ownership Amylyx Pharmaceuticals, Inc. (AMLX)
This table provides information about the institutional ownership of Amylyx Pharmaceuticals, Inc. (AMLX). We have compiled data on the 184 institutions that hold shares in the stock, with a total of 94.1 Million shares, which have been reported (via 13F filing form) to have a value of $1.19 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
1,107,008
shares
|
$14 Million
0.05% of portfolio
|
Q3 2025
Reduced 4.11%
|
|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Nov 14, 2025 Q3 2025 |
935,684
shares
|
$11.9 Million
0.52% of portfolio
|
Q3 2025
Reduced 68.11%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
866,202
shares
|
$11 Million
1.11% of portfolio
|
Q3 2025
Reduced 28.12%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
845,290
shares
|
$10.7 Million
0.06% of portfolio
|
Q3 2025
Reduced 29.58%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
822,237
shares
|
$10.4 Million
0.0% of portfolio
|
Q3 2025
Added 0.25%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
810,640
shares
|
$10.3 Million
0.0% of portfolio
|
Q3 2025
Added 38.13%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
750,600
shares
|
$9.53 Million
0.35% of portfolio
|
Q3 2025
Added 139.66%
|
|
|
Silverarc Capital Management, LLC
|
Nov 12, 2025 Q3 2025 |
700,000
shares
|
$8.88 Million
1.96% of portfolio
|
Q3 2025
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
645,185
shares
|
$8.19 Million
0.0% of portfolio
|
Q3 2025
Added 9.65%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2025 Q3 2025 |
612,841
shares
|
$7.78 Million
0.48% of portfolio
|
Q3 2025
New holding
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
601,646
shares
|
$7.63 Million
0.02% of portfolio
|
Q2 2023
Reduced 58.04%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
579,174
shares
|
$7.35 Million
0.98% of portfolio
|
Q3 2025
Reduced 10.9%
|
|
|
Jennison Associates LLC
|
Oct 30, 2025 Q3 2025 |
578,659
shares
|
$7.34 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
509,780
shares
|
$6.47 Million
0.0% of portfolio
|
Q3 2025
Added 36.4%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2025 Q3 2025 |
500,000
shares
|
$6.35 Million
1.08% of portfolio
|
Q3 2025
New holding
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
499,764
shares
|
$6.34 Million
0.45% of portfolio
|
Q2 2025
Added 45.61%
|
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
437,391
shares
|
$5.55 Million
6.13% of portfolio
|
Q3 2025
New holding
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
436,156
shares
|
$5.53 Million
0.5% of portfolio
|
Q3 2025
Reduced 40.44%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
429,516
shares
|
$5.45 Million
0.0% of portfolio
|
Q3 2025
Reduced 4.93%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
417,771
shares
|
$5.3 Million
0.0% of portfolio
|
Q3 2025
Reduced 72.37%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
414,112
shares
|
$5.26 Million
0.0% of portfolio
|
Q3 2025
Added 217.88%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
367,331
shares
|
$4.66 Million
0.01% of portfolio
|
Q3 2025
Reduced 35.45%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Nov 14, 2025 Q3 2025 |
333,258
shares
|
$4.23 Million
8.53% of portfolio
|
Q3 2025
New holding
|
|
|
Alpha Wave Global, LP
New York, NY |
Nov 13, 2025 Q3 2025 |
327,312
shares
|
$4.15 Million
2.22% of portfolio
|
Q3 2025
Added 18.66%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
325,000
shares
|
$4.12 Million
0.39% of portfolio
|
Q3 2024
New holding
|
|